Docetaxel (Taxotere) in the treatment of cancer
Burris, H.A.
Seminars in Oncology 27(2 Suppl 3: 1-2
2000
ISSN/ISBN: 0093-7754 PMID: 10810931 Document Number: 518569
Document emailed within 1 workday
Related Documents
Armand, J.P. 2000: Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27 Suppl. 2: 223-230Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Miller, V. 1999: Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer Seminars in Oncology 26(3 Suppl 10: 12-14
Lissoni, P.; Vaghi, M.; Ardizzoia, A.; Fumagalli, E.; Tancini, G.; Gardani, G.; Conti, A.; Maestroni, G.J. 2001: Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer Neuro Endocrinology Letters 22(1): 27-29
Belani, C.P. 1999: Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments Seminars in Oncology 26(3 Suppl 10: 15-18
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Bruno, R.; Sanderink, G.J. 1993: Pharmacokinetics and metabolism of Taxotere (docetaxel) Cancer Surveys 17: 305-313
Hortobagyi, G.N. 1999: Recent progress in the clinical development of docetaxel (Taxotere) Seminars in Oncology 26(3 Suppl. 9): 32-36
Burris, H.A. 1999: Single-agent docetaxel (Taxotere) in randomized phase III trials Seminars in Oncology 26(3 Suppl 9): 1-6
van Oijen, B.; Pleunis, M.; Erdkamp, F.; Prevoo, R.; van der Kuy, H. 2011: Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports International Journal of Clinical Pharmacology and Therapeutics 49(1): 46-48
Chen, M.; Crowson, A.Neil.; Woofter, M.; Luca, M.Beth.; Magro, C.M. 2004: Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases Journal of Rheumatology 31(4): 818-820
Distelmans, W.; Storme, G. 1999: The effect of pretreatment with docetaxel (taxotere; RP 56976) on irradiated subcutaneous MA 16/C murine tumors Journal of Experimental and Clinical Cancer Research: Cr 18(2): 167-172
Zhang, Y.-F.; Yu, Y.-F.; Lu, S. 2009: Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer Zhonghua Yi Xue Za Zhi 89(22): 1544-1548
Cascinu, S. 2001: Role of docetaxel in the treatment of gastric cancer Tumori 87(6): A10-A12
Wang, Z-Ping.; Sun, Y.; Zhang, X-Ru.; Zhang, M-Hong.; Wang, X-Wen.; Yu, X-Jun.; Nan, K-Jun.; Li, E-Xiao.; Liu, J-Wei.; Gao, Y-Jie.; Guan, X-Qian.; Song, S-Ping.; Sheng, L-Jun.; Wang, D-Lin.; Wang, Z-Xin. 2006: Docetaxel in the treatment of advanced breast cancer Zhonghua Zhong Liu Za Zhi 28(6): 468-470
Sparano, J.A. 1998: Compilation of phase i and Ii trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies Seminars in Oncology 25(6 Suppl 13: 10-15
Wada, T.; Kunisaki, C.; Hasegawa, S.; Kaida, S.; Tamura, S.; Ono, H.; Oshima, T.; Fujii, S.; Kosaka, T.; Makino, H.; Akiyama, H.; Endo, I. 2013: A case of locally advanced gastric cancer in which the patient underwent curative gastrectomy after treatment with systemic chemotherapy with bi-weekly s-1/docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(11): 1533-1536
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339
Mencoboni, M.; Rebella, L.; Tredici, S.; Ghio, R.; Scarpati, D.; Bavazzano, M.; Jankowska, B.; Delle Piane, M. 2005: Concurrent chemo-radiotherapy with taxotere and cisplatin in head and neck cancer: a feasibility study Anticancer Research 25(6c): 4451-4454